{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:28:47Z","timestamp":1728534527303},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,9]]},"DOI":"10.7759\/cureus.71144","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:16:45Z","timestamp":1728487005000},"source":"Crossref","is-referenced-by-count":0,"title":["Complex Pharmacodynamics of Aripiprazole and Haloperidol in Schizophrenia Management: A Case Report"],"prefix":"10.7759","author":[{"given":"Rihab","family":"Farooq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammara Shakil","family":"Sahibole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ali","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin A","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel KR","year":"2014","unstructured":"Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment options. Pharm Ther. 2014, 39:638-45.","journal-title":"Pharm Ther"},{"key":"ref2","article-title":"Haloperidol","author":"Rahman S","year":"2023","unstructured":"Rahman S, Marwaha R. Haloperidol. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","article-title":"Antipsychotic medications","author":"Chokhawala K","year":"2023","unstructured":"Chokhawala K, Stevens L. Antipsychotic medications. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X15666170413115754","article-title":"Aripiprazole, a drug that displays partial agonism and functional selectivity","volume":"15","author":"Tuplin EW","year":"2017","unstructured":"Tuplin EW, Holahan MR. Aripiprazole, a drug that displays partial agonism and functional selectivity. Curr Neuropharmacol. 2017, 15:1192-207. 10.2174\/1570159X15666170413115754","journal-title":"Curr Neuropharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2026","article-title":"Combining aripiprazole and haloperidol: focus on D2 receptor","volume":"62","author":"Crapanzano C","year":"2022","unstructured":"Crapanzano C, Laurenzi PF, Amendola C, Casolaro I. Combining aripiprazole and haloperidol: focus on D2 receptor. J Clin Pharmacol. 2022, 62:918. 10.1002\/jcph.2026","journal-title":"J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/13651501.2011.644300","article-title":"Severe psychotic exacerbation during combined treatment with aripiprazole\/haloperidol after prior treatment with risperidone","volume":"16","author":"Letmaier M","year":"2012","unstructured":"Letmaier M, Painold A, Holl AK, Grohmann R, Vergin H. Severe psychotic exacerbation during combined treatment with aripiprazole\/haloperidol after prior treatment with risperidone. Int J Psychiatry Clin Pract. 2012, 16:153-6. 10.3109\/13651501.2011.644300","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06071075","article-title":"Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial","volume":"164","author":"Shim JC","year":"2007","unstructured":"Shim JC, Shin JG, Kelly DL, et al.. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. Am J Psychiatry. 2007, 164:1404-10. 10.1176\/appi.ajp.2007.06071075","journal-title":"Am J Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0221d","article-title":"Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol","volume":"69","author":"Leo R","year":"2008","unstructured":"Leo R, Razzini C, Di Lorenzo G, et al.. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. J Clin Psychiatry. 2008, 69:327-8. 10.4088\/jcp.v69n0221d","journal-title":"J Clin Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307052-complex-pharmacodynamics-of-aripiprazole-and-haloperidol-in-schizophrenia-management-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T15:16:47Z","timestamp":1728487007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307052-complex-pharmacodynamics-of-aripiprazole-and-haloperidol-in-schizophrenia-management-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.71144","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}